Skip to main content
. 2020 Nov 26;100(4):1031–1038. doi: 10.1007/s00277-020-04345-3

Fig. 2.

Fig. 2

Relative dose doxorubicin CHOP-R-ESC study—age groups patients 61–80 years (n = 561)